Therapy News and Research

RSS

Comprehensive overview of vascular risk factors to Alzheimer's disease

Over the last 15 years, researchers have found a significant association between vascular diseases such as hypertension, atherosclerosis, diabetes type 2, hyperlipidemia, and heart disease and an increased risk of Alzheimer's disease.

6 Nov 2012

Fracture bracing systems: an interview with Steve Ingel, President for the Bracing & Supports Division of DJO Global

Surprisingly, there are significantly more medical treatment episodes for upper extremity fractures than for those of lower extremity. The vast majority of forearm, hand and wrist fractures occur in pediatrics and young adults as they tend to be more active and involved in sporting activities.

6 Nov 2012

Gene silencing technology used to fight RSV and influenza

New hope has arrived for the fight against two deadly viral infections, RSV and influenza, as Griffith researchers prepare to develop a cutting-edge approach to treatment delivery.

6 Nov 2012

Low-dose aspirin effective at preventing serious blood clots

Low-dose aspirin is a cheap and effective way to prevent potentially deadly blood clots in the leg or the lungs in patients who have had a previous blood clot a new study shows.

6 Nov 2012

Study shows how local anesthetics can improve motor skills of patients after stroke

Painkilling drugs that make many therapies possible are a blessing for patients. Thanks to modern anesthetics, not only can surgical operations be conducted without causing pain, they are also used for various diagnostic procedures. Anesthetics can be very useful in therapies for stroke patients, as psychologists and physicians of the Friedrich Schiller University Jena (Germany) and the University Hospital Jena are now able to prove.

6 Nov 2012

Patients with diabetes, multi-vessel coronary artery disease can benefit from bypass surgery

An international, clinical research trial has shown that patients with diabetes whose multi-vessel coronary artery disease is treated with bypass surgery live longer and are less likely to suffer severe complications like heart attacks than those who undergo angioplasty.

6 Nov 2012

Intravenous infusion of HDL cholesterol could reduce risk of subsequent heart attack

An intravenous infusion of good cholesterol could reduce the risk of a subsequent heart attack, researchers reported at the American Heart Association's Scientific Sessions 2012.

6 Nov 2012

Endo, Bioniche decide to end second Urocidin Phase III trial on non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.

5 Nov 2012

Living liver donors have QoL advantage

Living liver donors have a better quality of life than the general population, show the results of a Japanese study.

5 Nov 2012

Anti-TNF-α therapy reduces CVD risk in patients with rheumatoid arthritis

Patients with rheumatoid arthritis exhibit a sub-clinical vasculitis that may underlie their increased risk for cardiovascular disease, shows research.

5 Nov 2012

Imaging-based therapy benefits ‘wake-up stroke’ patients

Undertaking thrombolysis on the basis of magnetic resonance imaging findings in patients with stroke of unknown onset time may double their chances for a good outcome, say researchers.

5 Nov 2012

Rush’s AARTS program to improve quality of life of children and adults with autism

The Chicago region's first comprehensive center serving patients from childhood into young adulthood with autism spectrum disorders has been established at Rush University Medical Center.

4 Nov 2012

Pradaxa use does not appear to increase serious bleeding

The U.S. Food and Drug Administration (FDA) today announced the results of a Mini-Sentinel assessment that indicates bleeding rates associated with new use of Pradaxa (dabigatran etexilate mesylate) capsules do not appear to be higher than bleeding rates associated with new use of warfarin, which is consistent with observations from the pivotal RE-LY trial.

4 Nov 2012

New information related to kidney transplantation

Three studies presented during the American Society of Nephrology's Annual Kidney Week provide new information related to kidney transplantation—specifically, the post-transplant health of kidney donors and the racial disparities faced by children in need of transplants.

3 Nov 2012

One-day seminar to explore ophthalmic innovations

The newest ophthalmic innovations with market potential will be the focus of a one-day seminar in Seattle on May 3, 2013 that will connect scientists, venture capitalists, pharmaceutical representatives and others.

3 Nov 2012

Caltech-led team discovers enzyme responsible for neural crest cell development

During the early developmental stages of vertebrates-animals that have a backbone and spinal column, including humans-cells undergo extensive rearrangements, and some cells migrate over large distances to populate particular areas and assume novel roles as differentiated cell types.

3 Nov 2012

TeleMedTM announces launch of TeleMedTM Psychiatry

TeleMedTM announces the launch of TeleMedTM Psychiatry, a first-of-its-kind telepsychiatry solution designed to give mental health providers and patients scheduled access to one another through secure online video therapy, regardless of location.

3 Nov 2012

Bristol-Myers Squibb, Pfizer and Portola partner to conduct clinical study of PRT4445 and ELIQUIS

Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company and Pfizer Inc. today announced a clinical collaboration agreement to conduct a proof-of-concept study of PRT4445 and the investigational oral Factor Xa inhibitor ELIQUIS (apixaban).

3 Nov 2012

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a rare and deadly cholesterol disorder.

3 Nov 2012

Autism interventions are supported by varying levels of evidence, reveals new RAND study

Interventions designed to improve core deficits in children with autism spectrum disorders are supported by varying levels of evidence, highlighting the need for well-designed studies to better evaluate the interventions, according to a new RAND Corporation study.

3 Nov 2012

Therapy News and Research

Comprehensive overview of vascular risk factors to Alzheimer's disease

Fracture bracing systems: an interview with Steve Ingel, President for the Bracing & Supports Division of DJO Global

Gene silencing technology used to fight RSV and influenza

Low-dose aspirin effective at preventing serious blood clots

Study shows how local anesthetics can improve motor skills of patients after stroke

Patients with diabetes, multi-vessel coronary artery disease can benefit from bypass surgery

Intravenous infusion of HDL cholesterol could reduce risk of subsequent heart attack

Endo, Bioniche decide to end second Urocidin Phase III trial on non-muscle-invasive bladder cancer

Living liver donors have QoL advantage

Anti-TNF-α therapy reduces CVD risk in patients with rheumatoid arthritis

Imaging-based therapy benefits ‘wake-up stroke’ patients

Rush’s AARTS program to improve quality of life of children and adults with autism

Pradaxa use does not appear to increase serious bleeding

New information related to kidney transplantation

One-day seminar to explore ophthalmic innovations

Caltech-led team discovers enzyme responsible for neural crest cell development

TeleMedTM announces launch of TeleMedTM Psychiatry

Bristol-Myers Squibb, Pfizer and Portola partner to conduct clinical study of PRT4445 and ELIQUIS

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

Autism interventions are supported by varying levels of evidence, reveals new RAND study

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News